Structural Heart Occluders

This channel includes news and new technology innovations about structural heart occluders. These include information of surgical repair and transcatheter closure of PFO, VSD, ASD and LAA. Devices include the Amplatzer and the Gore Helex

News | May 16, 2011
May 16, 2011 - The German Supreme Court (BGH) declared a structural heart occluder patent case to be invalid. In the...
News | May 10, 2011
Alcohol Injections Safer, Less Costly Than Surgery for Thickened Heart Muscle May 10, 2011 – In a “real-world” test of...
News | March 07, 2011
March 4, 2011 - Occlutech GmbH received a favorable court ruling in Stockholm, Sweden in the ongoing patent...
News | November 15, 2010
November 15, 2010 - A catheter procedure that closes a hole in patients’ hearts appears to be no more effective than...
News | November 03, 2010
November 3, 2010 – The first patient has been enrolled into a study comparing a left atrial appendage (LAA) closure...
News | October 29, 2010
The first-in-man use of the Coherex WaveCrest left atrial appendage (LAA) occluder system was successfully performed...
News | October 25, 2010
October 25, 2010 – The Hague, Netherlands ruled in favor of Occlutech, a transcatheter structural heart occluder...
Feature | October 18, 2010
St. Jude Medical Inc. said it plans to acquire AGA Medical Holdings Inc. for about $1.3 billion. The purchase will...
News | October 04, 2010
October 4, 2010 – Germany will reimburse patients who have a left atrial appendage closure procedure in 2011. The...
News | September 28, 2010
September 28, 2010 – The Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium featured a live case...
News | September 22, 2010
September 23, 2010 – The first consensus document for treating structural heart disease has been published by the...

The Watchman device is a transcatheter left atrial appendage occluder. It is meant to be an alternative to blood thinners in preventing stroke in patients with atrial fibrillation.

Feature | September 07, 2010 | John Kao, M.D., FACC and Anupama Shivaraju, M.D.
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is a major risk factor for developing...

The Gore Helex septal occluder.

News | August 25, 2010
August 25, 2010 – Alleging infringement of a patent for its transcatheter cardiac septal occluder devices, AGA...
News | August 25, 2010
August 25, 2010 – There will be special tracks available for nurses and technologists and for the transcatheter...
News | August 12, 2010
August 12, 2010 – A 52-year-old male heart failure patient in Krakow, Poland, became the first human to receive the...